Scholars Central

Case reportPublished 16 Sep 2017

Prolonged Use of Dexmedetomidine Infusion in an Infant for Sedation as Adjuvant Therapy

Authors: Paola Genovese, Joseph Tobias, Anjana Kundu

Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA

Journal of Palliative Care & Medicine

Volume 7 · Issue 5 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Dexmedetomidine, a central and peripheral alpha-2 receptor agonist approved by the FDA for the use in patients 18 years old and older, it has been increasingly used in the pediatric population for sedation and analgesia due to its advantage of minimal respiratory depression and lack of abuse/dependence. This is a case report of a successful use of dexmedetomidine in an infant for 15 weeks achieving; symptom control, reduction in the dose of opioids and benzodiazepines by 50% and a safe transition to oral equivalents.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Palliative Care & Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Palliative Care & Medicine
  • SubjectAlternative & Palliative Care
  • BylineArticles whose byline prints “Paola Genovese”
  • BylineArticles whose byline prints “Joseph Tobias”
  • BylineArticles whose byline prints “Anjana Kundu”